Polymorphism of interferon-gamma gene at position+874 and clinical characteristics of chronic hepatitis C

被引:45
作者
Dai, Chia-Yen
Chuang, Wan-Long
Hsieh, Ming-Yen
Lee, Li-Po
Hou, Nai-Jen
Chen, Shinn-Cherng
Lin, Zu-Yau
Hsieh, Ming-Yuh
Wang, Liang-Yen
Tsai, Jun-Fa
Chang, Wen-Yu
Yu, Ming-Lung
机构
[1] Kaohsiung Med Univ, Dept Internal Med, Hepatobiliary Div, Kaohsiung Med Univ Hosp, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Fac Med, Coll Med, Div Gastroenterol, Kaohsiung 807, Taiwan
[3] Kaohsiung Med Univ, Dept Occupat Med, Kaohsiung Municipal Hsiao Kang Hosp, Kaohsiung 807, Taiwan
[4] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 807, Taiwan
关键词
D O I
10.1016/j.trsl.2006.04.005
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A T-to-A polymorphic sequence at position +874 in the interferon (IFN)-gamma gene (+874 IFN-gamma) might be associated with disease susceptibilities. To investigate the influence of +874 IFN-gamma polymorphism on the hepatitis C virus (HCV) viral load and the severity of liver disease, the single nucleotide polymorphism (SNIP) was determined in 302 histologically proved chronic hepatitis C (CHC) patients (M/F: 180/122, mean age: 48.8 +/- 11.6 years, HCV genotype 1b: 147 (48.7%), liver cirrhosis: 29 (9.6%)) by using a polymerase chain reaction-sequence specific primers (PCR-SSP) approach. The distribution of genotypes for +874 IFN-gamma were T/T: 12 (4.0%), T/A: 71 (23.5%), and A/A: 219 (72.5%) and 27.5% (83/302) of patients' inherited T allele. The mean age of patients without A allele was significantly lower than other patients (41.7 +/- 11.3 vs 49.2 +/- 11.5 years, P = 0.028). Patients with the T allele of +874 IFN-gamma had a significantly higher rate of liver cirrhosis than patients with homozygote A allele (15.7% vs 7.3%, P = 0.028). By multivariate logistic regression analyses, T allele of +874 IFN-gamma and age were independent factors associated with cirrhosis (odds ratio/95% confidence interval: 2.519/1.128-5.622 and 1.065/1.025-1.107, respectively). In conclusion, the authors' findings indicate that inheritance of +847 IFN-gamma polymorphism is associated with the cirrhosis in patients with CHC.
引用
收藏
页码:128 / 133
页数:6
相关论文
共 39 条
[1]   THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES [J].
ALTER, MJ ;
MARGOLIS, HS ;
KRAWCZYNSKI, K ;
JUDSON, FN ;
MARES, A ;
ALEXANDER, WJ ;
HU, PY ;
MILLER, JK ;
GERBER, MA ;
SAMPLINER, RE ;
MEEKS, EL ;
BEACH, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) :1899-1905
[2]   CA repeat allele polymorphism in the first intron of the human interferon-γ gene is associated with lung allograft fibrosis [J].
Awad, M ;
Pravica, V ;
Perrey, C ;
El Gamel, A ;
Yonan, N ;
Sinnott, PJ ;
Hutchinson, IV .
HUMAN IMMUNOLOGY, 1999, 60 (04) :343-346
[3]   Genotypic variation in the transforming growth factor-β1 gene -: Association with transforming growth factor-pi production, fibrotic lung disease, and graft fibrosis after lung transplantation [J].
Awad, MR ;
El-Gamel, A ;
Hasleton, P ;
Turner, DM ;
Sinnott, PJ ;
Hutchinson, IV .
TRANSPLANTATION, 1998, 66 (08) :1014-1020
[4]   Polymorphisms in tumour necrosis factor-α, transforming growth factor-β, interleukin-10, interleukin-6, interferon-γ, and outcome of hepatitis C virus infection [J].
Barrett, S ;
Collins, M ;
Kenny, C ;
Ryan, E ;
Keane, CO ;
Crowe, J .
JOURNAL OF MEDICAL VIROLOGY, 2003, 71 (02) :212-218
[5]   Role of cytokine gene polymorphism and hepatic transforming growth factor β1 expression in recurrent hepatitis C after liver transplantation [J].
Ben-Ari, Z ;
Pappo, O ;
Druzd, T ;
Sulkes, J ;
Klein, T ;
Samra, Z ;
Gadba, R ;
Tambur, AR ;
Tur-Kaspa, R ;
Mor, E .
CYTOKINE, 2004, 27 (01) :7-14
[6]   Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection [J].
Bièche, I ;
Asselah, T ;
Laurendeau, I ;
Vidaud, D ;
Degot, C ;
Paradis, V ;
Bedossa, P ;
Valla, DC ;
Marcellin, P ;
Vidaud, M .
VIROLOGY, 2005, 332 (01) :130-144
[7]   Aging and proinflammatory cytokines [J].
Bruunsgaard, H ;
Pedersen, M ;
Pedersen, BK .
CURRENT OPINION IN HEMATOLOGY, 2001, 8 (03) :131-136
[8]   Treatment of chronic hepatitis C in southern Taiwan [J].
Chuang, WL ;
Yu, ML ;
Dai, CY ;
Chang, WY .
INTERVIROLOGY, 2005, 49 (1-2) :99-106
[9]   Tumor necrosis factor-α promoter polymorphism at position-308 predicts response to combination therapy in hepatitis C virus infection [J].
Dai, CY ;
Chuang, WL ;
Chang, WY ;
Chen, SC ;
Lee, LP ;
Hsieh, MY ;
Hou, NJ ;
Lin, ZY ;
Huang, JF ;
Hsieh, MY ;
Wang, LY ;
Yu, ML .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (01) :98-101
[10]   Polymorphisms in the interferon-γ gene at position+874 in patients with chronic hepatitis C treated with high-dose interferon-α and ribavirin [J].
Dai, CY ;
Chuang, WL ;
Chang, WY ;
Chen, SC ;
Lee, LP ;
Hsieh, MY ;
Hou, NJ ;
Lin, ZY ;
Hsieh, MY ;
Wang, LY ;
Yu, ML .
ANTIVIRAL RESEARCH, 2005, 67 (02) :93-97